Search / Trial NCT06231914

Efficacy and Safety of Fractional 1064-nm Picosecond Laser for Facial Skin Tightening

Launched by MAHIDOL UNIVERSITY · Jan 21, 2024

Trial Information

Current as of December 21, 2024

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness and safety of a special type of laser, called the fractional 1064-nm picosecond laser, to help tighten facial skin. Researchers want to find out how well this treatment reduces wrinkles, improves skin elasticity, and enhances overall skin texture and appearance. Participants in the study will receive three laser treatment sessions, each spaced four weeks apart, and will have follow-up visits at one, three, and six months after their last session to see how their skin has changed.

To be eligible for this trial, participants should be between 40 and 55 years old, have a body mass index (BMI) of less than 25, and have mild to moderate skin laxity. They should also be of Asian descent. However, individuals who are pregnant or breastfeeding, have had certain skin treatments in the past six months, have active skin infections, or have a history of severe scarring are not eligible. Overall, this trial aims to provide valuable information about a new treatment option for those looking to improve their facial skin.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Aged 40-55 years
  • BMI \< 25 kg/m2
  • Asian
  • Mild to moderate facial skin laxity using quantitative grading scale (grade 1.5-2.5)
  • Exclusion Criteria:
  • Pregnant or lactation
  • Subjects who have been treated with any kind of energy-based device 6 months prior to the inclusion
  • Subjects who have been injected with botulinum toxin, filler, or platelet-rich plasma on their faces 6 months prior to the inclusion
  • Active skin infections
  • History of hypertrophic scars or keloids

Trial Officials

Woraphong Manuskiatti, MD

Principal Investigator

Mahidol University

About Mahidol University

Mahidol University, a premier institution in Thailand, is dedicated to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the university leverages its extensive expertise in medical and health sciences to facilitate rigorous scientific investigations aimed at improving patient care and public health outcomes. With a commitment to ethical practices and collaboration, Mahidol University fosters multidisciplinary approaches, engaging a diverse array of researchers and healthcare professionals to drive meaningful advancements in clinical research.

Locations

Bangkok, , Thailand

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0